Ï㽶ÊÓƵ

Psychiatry Presentations

Health Anxiety and Somatic Symptom Disorder

Dr. Daniel ZigmanDaniel Zigman is an Assistant Professor with the Department of Psychiatry at Ï㽶ÊÓƵ and an attending staff at the Ï㽶ÊÓƵ Health Centre. He is the medical director of the MUHC Anxiety Program where he specializes in evaluation and management of treatment resistant anxiety, trauma related and obsessive compulsive disorders. He is also the psychiatrist for the CSSS de la Montagne Assertive Community Treatment Team, where his team works to support patients with severe and persistent mental illness to live independently in the community.

Ìý

Learning Objectives:

  1. Understand the diagnostic criteria and clinical presentation of Illness Anxiety Disorder and Somatic Symptom Disorder
  2. Have an approach to engaging these patients in appropriate treatment
  3. Explain effective pharmacological and psychological treatments for these conditions

ECT vs. TMS in the Treatment of Severe Depression

Dr. Michaela BarbarosieDr. Michaela Barbarosie is an Assistant Professor within the Department of Psychiatry and the Director of the Neuromodulation Unit at the Allan Memorial Institute and she also acts as Neuropsychiatrist, part of the MS Clinic at the Montreal Neurological Hospital. She studied medicine at Université de Montréal and completed her residency in psychiatry at McGill. Dr Barbarosie has a background in basic and clinical Neuroscience, having completed a PhD in Neurophysiology at the MNI, as well as a postdoctoral fellowship at Brown University, investigating animal models of learning and memory. She is interested in new treatments for major depression, other mood and anxiety disorders, using neuromodulation such as rTMS and tDCS and in neuropsychiatric manifestations of neurological disease

Learning Objectives:

  1. Understand the indications for ECT and rTMS
  2. Understand some mechanisms involved in ECT and rTMS
  3. Be able to list possible adverse effects associated with rTMS and with ECT
  4. Be able to educate patients on rTMS and ECT treatments and avoid stigma associated with either

Explosion of the Need for Services in and after the Pandemic

Jesse RenaudJesse Renaud is a clinical psychologist and the Team Leader of the MUHC Cognitive Behavioural Therapy Unit. She is also an assistant professor in the Department of Psychiatry at Ï㽶ÊÓƵ. Dr. Renaud’s research program examines the impact of the COVID-19 pandemic on the effectiveness of psychological interventions for psychiatric outpatients. Her work in this area has been supported by internal and external grants, including the Canadian Psychological Association’s Trauma Section Early Career Research Grant and the Senator W. David Angus Award for Research into Major Psychiatric Diseases.

Learning Objectives:

  1. Identify which individuals continue to be negatively impacted by the pandemic
  2. Identify interventions that contributed to good outcomes for psychiatric patients in Quebec
  3. Identify the future directions that will be implemented to improve mental health service delivery following lessons learned during the pandemic

Treatment of Schizophrenia in the Primary Care Setting

Dr. Howard Margolese

Ìý

Director, PEPP-MUHC (program for the evaluation & prevention of psychosis), &Schizophrenia program, MUHC Program director, Clinical Pharmacology and Toxicology residency program, Ï㽶ÊÓƵ Associate Professor, Department of Psychiatry, Ï㽶ÊÓƵ.

Ìý

Ìý

Learning Objectives:

  1. Understand what to do when they are following patients with schizophrenia
  2. Develop an approach to initiating treatment for psychosis/schizophrenia when patients refuse to see psychiatry
  3. Learn about order sets and other tools when following patient with schizophrenia

McGill Medicine CPD Office Fb View Content

Back to top